ALD-ALM Global specialist researchers

(Version 1. 08/2012) Austria Johannes Berger, Ph.D. Medical University of Vienna, Austria. Co-ordinator of the Community Research and Development Information Services (CORDISs) Integrated project to decipher the biological function of peroxisomes in health and disease. Contact details: johannes.berger@meduniwien.ac.uk

Belgium Myriam Baes, Ph.D. Laboratory for Cell Metabolism, Katholieve University, Leuven, Belgium. Active in the CORDIS integrated project to decipher the biological function of peroxisomes in health and disease. Contact details: myriam.baes@pharm.ku;euven.be

Germany Celia Kassmann, Ph.D. Klaus-Armin Nave, Ph.D. Max-Planck Institute of Experimental Medicine, Gottingen, Germany. The Myelin Project Research entitled Peroxisomal purification and degeneration A therapeutic approach in AMN mice. Contact details: o o Italy Anna Maria Cimini, Ph.D Department of Basic and Applied Biology, University of LAquila, Italy. Research includes Neurobiology and gene and cell therapy. Contact details: cimini@univaq.it C. Kassman: kassmann@em.mpg.de K-A. Nave: nave@em.mpg.de

ALD-ALM Global specialist researchers

(Version 1. 08/2012) Antonio Federico, Ph.D. Department Director of Neurology and Behaviour, University of Siena, Italy. Research interests include a variety of inborn neurological diseases. Contact details: federico@unisi.it

France Patrick Aubourg, M.D. Saint-Vincent de Paul Hospital, Paris, France. Specialist research includes X -linked Adrenoleukodystrophy (ALD), metachromatic Leukodystrophy Disease (MLD), & Neurofibromatosis. Contact details: patrick.aubourg@inserm.fr

Nathalie Cartier, Ph.D. INSERM, Department of pediatric Endocrinology and Neurology, Hospital Bicentre, Paris, France. Research includes haemopoietic cell gene therapy for ALD. Contact details: nathalie.cartier@inserm.fr

The United Kingdom Colin Stewart, Ph.D. BMT Unit, Bristol Royal Hospital for Children, Bristol, UK. Specialist research includes the identification of novel genetic diseases and areas of under -diagnosis, e.g. the link between Addisons Disease and ALD. Contact details: colin.steward@nildram.co.uk

Spain

Aurora Pujol, M.D. Neurometabolic Diseases Lab, IDIBELL, Barcelona, Spain. Interested in the genetic analysis of neurometabolic diseases. Contact details: apujol@idibell.cat

ALD-ALM Global specialist researchers

(Version 1. 08/2012) The Netherlands Stephan Kemp, Ph.D. Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, The Netherlands. Specialist research in the clinical, biochemical, genetic, and pathology of X-ALD, including novel therapies e.g. Benzafibrate. Contact details: s.kemp@amc.uva.nl

Bwee Tien Poll, Ph.D. University of Amsterdam, The Netherlands. Specialist research includes the biology of peroxisomes. Contact details: b.t.pollthe@amc.nl

The United States of A merica Ann Moser, Ph.D. (Co-Director) Richard Jones, Ph.D. (Co-Director) Other lab members: Amy Bastian, Ph.D. Lena Bezman, M.D. Michael Cataldo, Ph.D. S. Ali Fatemi, M.D. SakkBai Naidu, M.D. James Peker, Ph.D. Steven Steinberg, Ph.D. Carol Tiffany, M.S. Paul Watkings, M.D., Ph.D. Kathleen Zacowski, Ph.D. Peter Van Zijl, Ph.D. Neurogenetics Research Center, K.Kreiger Institute, Baltimore, USA. Specialist research in various areas including Peroxisomal Diseases Section of the Genetics Laboratories . Contact details (Co-Directors): o o Moser, A: mosera@kennedykrieger.org Jones, R: jonesri@kennedykrieger.org

ALD-ALM Global specialist researchers

(Version 1. 08/2012) Ian Duncan, Ph.D. University of Wisconsin, Madison, USA. The Myelin Project Research entitled Roles of Microgliamacrophages and their therapeutic use in combination with lentiviral gene transfer in Krabbes Disease. Contact details: duncani@svm.vetmed.wisc.edu

Paul Orchard, M.D. University of Minnesota, Minneapolis, USA. Interested in the use of hematopoietic cell transplantation for genetic metabolic and storage diseases. Contact details: orcha001@umn.edu

Weston Miller, M.D. University of Minnesota, Minneapolis, USA. Interests include stem cell transplantat ion for metabolic disorders, including ALD-AMN. Contact details: mill4991@umn.edu

Gerald Raymond, M.D. Kennedy Krieger Institute, Baltimore, USA. The Myelin Project Research entitled Lorenzos Oil Clinical Study. Contact details: raymond@kennedykrieger.org

Joanne Kurtzberg, M.D. Duke University, Durham, USA. Specialist research includes transplantation therapy for inborn errors of metabolism. Contact details: kurtz001@mc.duke.edu

Mitchell Cairo, M.D. Columbia University, New York, USA.

ALD-ALM Global specialist researchers

(Version 1. 08/2012) Specialised research includes Human Placental -Derived Stem Cell Transplantation (clinica l trial director, New York Medical College). Contact details: mc1310@columbia.edu

Mark Sands, Ph.D. Department of Medicine, Oncology Division, Washington University, St. Louis, USA. Lysosomal storage disease (LSD) specialist. Contact details: msands@dom.wustl.edu

Canada Michel Sylvain, M.D. Chul Hospital, Quebec, Canada. Specialist in Paediatric Neurology. Contact details: Tel only available: (418) 654-2708.

Bernard Brais, M.D. Montreal Neurological Institute and Hospital, Quebec, Canada. Co-directs the neuromuscular group within the hospital. Contact details: Bernard.brais@umontreal.ca

Taiwan Jao Shwann Liang, M.D. Far Eastern Memorial Hospital, New TaiPei City 220, Taiwan. Research orientated around Paediatric Neurology , including X-ALD. Contact details: Liang@imcir.twmu.ac.jp